Endovascular embolization treatment of cerebral arteriovenous malformation with Glubran (NBCA-MS)

VernacularTitle:Glubran(NBCA-MS)胶栓塞脑动静脉畸形临床研究
Author: Xue-Tao WANG ¹ ; Chuan-Zhi DUAN ; Qiu-Jing WANG ; Zhi-Wei HUANG ; Yan-Wu GUO ; Xiao-Qiu LIU
Author Information

1. 南方医科大学珠江医院
Keywords: Intracranial arteriovenous malformations; Embolization,therapeutic; NBCA; Follow-up studies
From: Chinese Journal of Neuromedicine 2008;7(5):487-490
CountryChina
Language:Chinese
Abstract: Objective To explore the clinical skills and curative efficacy of Glubran (NBCA-MS) embolization of cerebral arteriovenous malformations. Methods Ninety-six cases of cerebral arteriovenous malformations were treated by 187 endovascular embolizations with different concentrations of Italy GEM company's Glubran (NBCA-MS). Follow-up was performed to 96 cases of cerebral arteriovenous malformation with NBCA-MS embolization. Results During the follow-up in 96 cases, clinical symptoms completely disappeared in 92, were improved in 3 and reoccurred in 1. The malformation was totally got rid of in 44 of 48 cases DSA examinated, and the 80%-90% embolization was achieved in the rest who need further γ-knife therapy. In all cases, γ-knife therapy was performed in 32 cases after embolization, and among them 26 cases received DSA examination 1-2 years after γ-knife therapy, and 21 cases were proved to have no malformation. Conclusions The method ofendovascular emdolization with NBCA-MS is safe, reliable and effective to treat the cerebral arteriovenous malformation.